What do we know about the role of regulatory B cells (Breg) during the course of infection of two major parasitic diseases, malaria and leishmaniasis?

References

• Lund FE. Cytokine-producing B lymphocytes-key regulators of immunity. Curr Opin Immunol. 2008;20(3):332–338.10.1016/j.coi.2008.03.003
   PubMed Web of Science ®Google Scholar
• Welner RS, Pelayo R, Kincade PW. Evolving views on the genealogy of B cells. Nat Rev Immunol. 2008;8(2):95–106.10.1038/nri2234
   PubMed Web of Science ®Google Scholar
• Borhis G, Richard Y. Subversion of the B-cell compartment during parasitic, bacterial, and viral infections. BMC Immunol. 2015;16(15):1–10.
   PubMed Web of Science ®Google Scholar
• DiLillo DJ, Hamaguchi Y, Ueda Y, et al. Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice. J Immunol. 2008;180(1):361–371.10.4049/jimmunol.180.1.361
   PubMed Web of Science ®Google Scholar
• LeBien TW, Tedder TF. B lymphocytes: how they develop and function. Blood. 2008;112(5):1570–1580.10.1182/blood-2008-02-078071
   PubMed Web of Science ®Google Scholar
• Han J, Sun L, Fan X, et al. Role of regulatory B cells in neuroimmunologic disorders. J Neurosci Res. 2016;94(8):693–701.10.1002/jnr.v94.8
   PubMed Web of Science ®Google Scholar
• Liu Y, Wu Y, Ramarathinam L, et al Gene-targeted B-deficient mice reveal a critical role for B cells in the CD4 T cell response. Int Immunol. 1995;7(8):1353-1362.10.1093/intimm/7.8.1353
   PubMed Web of Science ®Google Scholar
• Tedder TF. B10 cells: a functionally defined regulatory B cell subset. J Immunol. 2015;194(4):1395–1401.10.4049/jimmunol.1401329
   PubMed Web of Science ®Google Scholar
• Harris DP, Haynes L, Sayles PC, et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol. 2000;1(6):475–482.10.1038/82717
   PubMed Web of Science ®Google Scholar
• Shlomchik MJ, Craft JE, Mamula MJ. From T to B and back again: positive feedback in systemic autoimmune disease. Nat Rev Immunol. 2001;1(2):147–153.10.1038/35100573
   PubMed Web of Science ®Google Scholar
• Katz SI, Parker D, Turk JL. B-cell suppression of delayed hypersensitivity reactions. Nature. 1974;251:550–551.10.1038/251550a0
   PubMed Web of Science ®Google Scholar
• Neta R, Salvin SB. Specific suppression of delayed hypersensitivity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity. J Immunol. 1974;113(6):1716–1725.
   PubMed Web of Science ®Google Scholar
• Fillatreau S, Sweenie CH, McGeachy MJ, et al. B cells regulate autoimmunity by provision of IL-10. Nat Immunol. 2002;3(10):944–950.10.1038/ni833
   PubMed Web of Science ®Google Scholar
• Mizoguchi A, Mizoguchi E, Takedatsu H, et al. Chronic intestinal inflammatory condition generates IL-10-producing regulatory B cell subset characterized by CD1d upregulation. Immunity. 2002;16(2):219–230.10.1016/S1074-7613(02)00274-1
   PubMed Web of Science ®Google Scholar
• Mauri C, Gray D, Mushtaq N, et al. Prevention of arthritis by interleukin 10–producing B cells. J Exp Med. 2003;197(4):489–501.10.1084/jem.20021293
   PubMed Web of Science ®Google Scholar
• Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function. Immunity. 2015;42(4):607–612.10.1016/j.immuni.2015.04.005
   PubMed Web of Science ®Google Scholar
• Yanaba K, Bouaziz JD, Haas KM, et al. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity. 2008;28(5):639–650.10.1016/j.immuni.2008.03.017
   PubMed Web of Science ®Google Scholar
• DiLillo DJ, Matsushita T, Tedder TF. B10 cells and regulatory B cells balance immune responses during inflammation, autoimmunity, and cancer. Ann NY Acad Sci. 2010;1183(2010):38–57.10.1111/j.1749-6632.2009.05137.x
   PubMed Web of Science ®Google Scholar
• Wei B, Velazquez P, Turovskaya O, et al. 2005. Mesenteric B cells centrally inhibit CD4+ T cell colitis through interaction with regulatory T cell subsets. Proc Natl Acad Sci USA. 2005;102(6):2010-2015.10.1073/pnas.0409449102
   PubMed Web of Science ®Google Scholar
• Gray M, Miles K, Salter D, et al. Apoptotic cells protect mice from autoimmune inflammation by the induction of regulatory B cells. Proc Natl Acad Sci USA. 2007;104(35):14080–14085.10.1073/pnas.0700326104
   PubMed Web of Science ®Google Scholar
• Mauri C, Blair PA. Regulatory B cells in autoimmunity: developments and controversies. Nat Rev Rheumatol. 2010;6(11):636–643.10.1038/nrrheum.2010.140
   PubMed Web of Science ®Google Scholar
• Mauri C, Bosma A. Immune regulatory function of B cells. Annu Rev Immunol. 2012;30:221–241.10.1146/annurev-immunol-020711-074934
   PubMed Web of Science ®Google Scholar
• Evans JG, Chavez-Rueda KA, Eddaoudi A, et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol. 2007;178(12):7868–7878.10.4049/jimmunol.178.12.7868
   PubMed Web of Science ®Google Scholar
• Blair PA, Chavez-Rueda KA, Evans JG, et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol. 2009;182(6):3492–3502.10.4049/jimmunol.0803052
   PubMed Web of Science ®Google Scholar
• Iwata Y, Matsushita T, Horikawa M, et al. Characterization of a rare IL-10–competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011;117(2):530–541.10.1182/blood-2010-07-294249
   PubMed Web of Science ®Google Scholar
• Khoder A, Sarvaria A, Alsuliman A, et al. Regulatory B cells are enriched within the IgM memory and transitional subsets in healthy donors but are deficient in chronic GVHD. Blood. 2014;124(13):2034–2045.10.1182/blood-2014-04-571125
   PubMed Web of Science ®Google Scholar
• Blair PA, Noreña LY, Flores-Borja F, et al. CD19+CD24hiCD38hi B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients. Immunity. 2010;32(1):129–140.10.1016/j.immuni.2009.11.009
   PubMed Web of Science ®Google Scholar
• Flores-Borja F, Bosma A, Ng D, et al. CD19+CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med. 2013;5(173):173ra23.10.1126/scitranslmed.3005407
   PubMed Web of Science ®Google Scholar
• Xiao S, Brooks CR, Zhu C, et al. Defect in regulatory B-cell function and development of systemic autoimmunity in T-cell Ig mucin 1 (Tim-1) mucin domain-mutant mice. Proc Natl Acad Sci USA. 2012;109(30):12105–12110.10.1073/pnas.1120914109
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Baba A, Yokota T, et al. Interleukin-10-producing plasmablasts exert regulatory function in autoimmune inflammation. Immunity. 2014;41(6):1040–1051.10.1016/j.immuni.2014.10.016
   PubMed Web of Science ®Google Scholar
• Shen P, Roch T, Lampropoulou V, et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature. 2014;507(7492):366–370.10.1038/nature12979
   PubMed Web of Science ®Google Scholar
• O’garra A, Chang R, Go N, et al. Ly‐1 B (B‐1) cells are the main source of B cell‐derived interleukin 10. Eur J Immunol. 1992;22(3):711–717.10.1002/(ISSN)1521-4141
   PubMed Web of Science ®Google Scholar
• Mizoguchi A, Mizoguchi E, Smith RN, et al. Suppressive role of B cells in chronic colitis of T cell receptor α mutant mice. J Exp Med. 1997;186(10):1749–1756.10.1084/jem.186.10.1749
   PubMed Web of Science ®Google Scholar
• Mauri C, Menon M. The expanding family of regulatory B cells. Int Immunol. 2003;27(10):479–486.
   Web of Science ®Google Scholar
• Mizoguchi A, Bhan AK. A case for regulatory B cells. J Immunol. 2006;176(2):705–710.10.4049/jimmunol.176.2.705
   PubMed Web of Science ®Google Scholar
• Saraiva M, O’Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol. 2010;10(3):170–181.10.1038/nri2711
   PubMed Web of Science ®Google Scholar
• Douglas RS, Woo EY, Capocasale RJ, et al. Altered response to and production of TGF-beta by B cells from autoimmune NZB mice. Cell. Immunol. 1997;179:126–137.10.1006/cimm.1997.1149
   PubMed Web of Science ®Google Scholar
• Wang RX, Yu CR, Dambuza IM, et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med. 2014;20(6):633–641.10.1038/nm.3554
   PubMed Web of Science ®Google Scholar
• Egwuagu CE, Yu CR. Interleukin 35-producing B cells (I35-Breg): a new mediator of regulatory B-cell functions in CNS autoimmune diseases. Crit Rev Immunol. 2015;35(1):49–57.10.1615/CritRevImmunol.v35.i1
   PubMed Web of Science ®Google Scholar
• Natarajan P, Singh A, McNamara JT, et al. Regulatory B cells from hilar lymph nodes of tolerant mice in a murine model of allergic airway disease are CD5+, express TGF-beta, and co-localize with CD4+Foxp3+ T cells. Mucosal Immunol. 2012;5(6):691–701.10.1038/mi.2012.42
   PubMed Web of Science ®Google Scholar
• Yang M, Sun L, Wang S, et al. Novel function of B cell-activating factor in the induction of IL-10–Producing regulatory B cells. J Immunol. 2010;184(7):3321–3325.10.4049/jimmunol.0902551
   PubMed Web of Science ®Google Scholar
• Cepok S, Rosche B, Grummel V, et al. Short-lived plasma blasts are the main B cell effector subset during the course of multiple sclerosis. Brain. 2005;128:1667–1676.10.1093/brain/awh486
   PubMed Web of Science ®Google Scholar
• Krumbholz M, Theil D, Derfuss T, et al. BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med. 2005;201(2):195–200.
   PubMed Web of Science ®Google Scholar
• Hartung HP, Kieseier BC. Atacicept: targeting B cells in multiple sclerosis. Ther Adv Neurol Disord. 2010;3(4):205–216.10.1177/1756285610371146
   PubMedGoogle Scholar
• Magliozzi R, Howell O, Vora A, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain. 2007;130(4):1089–1104.
   PubMed Web of Science ®Google Scholar
• Ramanujam M, Davidson A. BAFF blockade for systemic lupus erythematosus: will the promise be fulfilled? Immunol Rev. 2008;223:156–174.10.1111/imr.2008.223.issue-1
   PubMed Web of Science ®Google Scholar
• Gross JA, Dillon SR, Mudri S, et al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease impaired B cell maturation in mice lacking BLyS. Immunity. 2001;15:289–302.
   PubMed Web of Science ®Google Scholar
• Wei F, Chang Y, Wei W. The role of BAFF in the progression of rheumatoid arthritis. Cytokine. 2015;76(2):537–544.10.1016/j.cyto.2015.07.014
   PubMed Web of Science ®Google Scholar
• Jamin C, Morva A, Lemoine S, et al. Regulatory B lymphocytes in humans: a potential role in autoimmunity. Arthritis Rheum. 2008;58(7):1900–1906.10.1002/art.v58:7
   PubMed Web of Science ®Google Scholar
• Noh G, Lee JH. Regulatory B cells and allergic diseases. Allergy Asthma Immunol Res. 2011;3(3):168–177.10.4168/aair.2011.3.3.168
   PubMed Web of Science ®Google Scholar
• Berthelot JM, Jamin C, Amrouche K, et al. Regulatory B cells play a key role in immune system balance. Joint Bone Spine. 2013;80(1):18–22.10.1016/j.jbspin.2012.04.010
   PubMed Web of Science ®Google Scholar
• Mauri C, Ehrenstein MR. The ‘short’ history of regulatory B cells. Trends Immunol. 2008;29(1):34–40.10.1016/j.it.2007.10.004
   PubMed Web of Science ®Google Scholar
• Sato S, Steeber DA, Tedder TF. The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc Natl Acad Sci USA. 1995;92:11558–11562.10.1073/pnas.92.25.11558
   PubMed Web of Science ®Google Scholar
• Ma K, Li J, Fang Y, et al. Roles of B cell-intrinsic TLR signals in systemic lupus erythematosus. Int J Mol Sci. 2015;16(6):13084–13105.10.3390/ijms160613084
   PubMed Web of Science ®Google Scholar
• Barr TA, Brown S, Ryan G, et al. TLR-mediated stimulation of APC: Distinct cytokine responses of B cells and dendritic cells. Eur J Immunol. 2007;37(11):3040–3053.10.1002/(ISSN)1521-4141
   PubMed Web of Science ®Google Scholar
• Chiron D, Bekeredjian-Ding I, Pellat-Deceunynck C, et al. Toll-like receptors: lessons to learn from normal and malignant human B cells. Blood. 2008;112(6):2205–2213.10.1182/blood-2008-02-140673
   PubMed Web of Science ®Google Scholar
• Connolly DJ, O’Neill LA. New developments in Toll-like receptor targeted therapeutics. Curr Opin Pharmacol. 2012;12(4):510–518.10.1016/j.coph.2012.06.002
   PubMed Web of Science ®Google Scholar
• Klinker MW, Lundy SK. Multiple mechanisms of immune suppression by B lymphocytes. Mol Med. 2012;18(1):123.
   PubMed Web of Science ®Google Scholar
• Yang M, Deng J, Liu Y, et al. IL-10–producing regulatory B10 cells ameliorate collagen-induced arthritis via suppressing Th17 cell generation. Am J Pathol. 2012;180(6):2375–2385.10.1016/j.ajpath.2012.03.010
   PubMed Web of Science ®Google Scholar
• Lindner S, Dahlke K, Sontheimer K, et al. Interleukin 21–induced granzyme B-expressing B cells infiltrate tumors and regulate T cells. Cancer Res. 2013;73(8):2468–2479.10.1158/0008-5472.CAN-12-3450
   PubMed Web of Science ®Google Scholar
• DiLillo DJ, Weinberg JB, Yoshizaki A, et al. Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function. Leukemia. 2013;27(1):170–182.10.1038/leu.2012.165
   PubMed Web of Science ®Google Scholar
• Candando KM, Lykken JM, Tedder TF. B10 cell regulation of health and disease. Immunol Rev. 2014;259(1):259–272.10.1111/imr.12176
   PubMed Web of Science ®Google Scholar
• Lykken JM, Candando KM, Tedder TF. Regulatory B10 cell development and function. Int Immunol. 2015;27(10):471–477.10.1093/intimm/dxv046
   PubMed Web of Science ®Google Scholar
• Inoue S, Leitner WW, Golding B, et al. Inhibitory effects of B cells on antitumor immunity. Cancer Res. 2006;66(15):7741–7747.10.1158/0008-5472.CAN-05-3766
   PubMed Web of Science ®Google Scholar
• Das A, Ellis G, Pallant C, et al. IL-10–producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol. 2012;189(8):3925–3935.10.4049/jimmunol.1103139
   PubMed Web of Science ®Google Scholar
• Siewe B, Stapleton JT, Martinson J, et al. Regulatory B cell frequency correlates with markers of HIV disease progression and attenuates anti-HIV CD8⁺ T cell function in vitro. J Leukoc Biol. 2013;93(5):811–818.10.1189/jlb.0912436
   PubMed Web of Science ®Google Scholar
• Liu J, Zhan W, Kim CJ, et al. IL-10–producing B cells are induced early in HIV-1 infection and suppress HIV-1–specific T cell responses. PLoS One. 2014;9(2):e89236.10.1371/journal.pone.0089236
   PubMed Web of Science ®Google Scholar
• Majlessi L, Lo-Man R, Leclerc C. Regulatory B and T cells in infections. Microbes Infect. 2008;10(9):1030–1035.10.1016/j.micinf.2008.07.017
   PubMed Web of Science ®Google Scholar
• Neves P, Lampropoulou V, Calderon-Gomez E, et al. Signaling via the MyD88 adaptor protein in B cells suppresses protective immunity during Salmonella typhimurium infection. Immunity. 2010;33(5):777–790.10.1016/j.immuni.2010.10.016
   PubMed Web of Science ®Google Scholar
• Goenka R, Parent MA, Elzer PH, et al. B cell–deficient mice display markedly enhanced resistance to the intracellular bacterium Brucella abortus. J Infect Dis. 2011;203(8):1136–1146.10.1093/infdis/jiq171
   PubMed Web of Science ®Google Scholar
• Velupillai P, Secor WE, Horauf AM, et al. B-1 cell (CD5+B220+) outgrowth in murine schistosomiasis is genetically restricted and is largely due to activation by polylactosamine sugars. J Immunol. 1997;158(1):338–344.
   PubMed Web of Science ®Google Scholar
• Gaubert S, Viana da Costa A, Maurage CA, et al. X–linked immunodeficiency affects the outcome of Schistosoma mansoni infection in the murine model. Parasite Immunol. 1999;21(2):89–101.10.1046/j.1365-3024.1999.00205.x
   PubMed Web of Science ®Google Scholar
• Mangan NE, Fallon RE, Smith P, et al. Helminth infection protects mice from anaphylaxis via IL-10–producing B cells. J Immunol. 2004;173(10):6346–6356.10.4049/jimmunol.173.10.6346
   PubMed Web of Science ®Google Scholar
• Amu S, Saunders SP, Kronenberg M, et al. Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3–positive T regulatory cells in a murine model. J Allergy Clin Immunol. 2010;125(5):1114–1124.10.1016/j.jaci.2010.01.018
   PubMed Web of Science ®Google Scholar
• Van der Vlugt LE, Labuda LA, Ozir-Fazalalikhan A, et al. Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells. PLoS One. 2012;7(2):e30883.10.1371/journal.pone.0030883
   Google Scholar
• Van der Vlugt LE, Zinsou JF, Ozir-Fazalalikhan A, et al. Interleukin 10 (IL-10) –producing CD1dhi regulatory B cells from Schistosoma haematobium–infected individuals induce IL-10–positive T cells and suppress effector T-cell cytokines. J Infect Dis. 2014;210(8):1207–1216.10.1093/infdis/jiu257
   PubMed Web of Science ®Google Scholar
• Velupillai P, Harn DA. Oligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome–infected mice: a mechanism for regulation of CD4+ T–cell subsets. Proc Natl Acad Sci USA. 1994;91(1):18–22.10.1073/pnas.91.1.18
   PubMed Web of Science ®Google Scholar
• Ronet C, Hauyon-La Torre Y, Revaz-Breton M, et al. Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. J Immunol. 2010;184(2):886–894.10.4049/jimmunol.0901114
   PubMed Web of Science ®Google Scholar
• Bankoti R, Gupta K, Levchenko A, et al. Marginal zone B cells regulate antigen-specific T cell responses during infection. J Immunol. 2012;188(8):3961–3971.10.4049/jimmunol.1102880
   PubMed Web of Science ®Google Scholar
• Bao LQ, Huy NT, Kikuchi M, et al. CD19(+) B cells confer protection against experimental cerebral malaria in semi-immune rodent model. PLoS One. 2013;8(5):e64836.10.1371/journal.pone.0064836
   Google Scholar
• Liu Y, Chen Y, Li Z, et al. Role of IL-10–producing regulatory B cells in control of cerebral malaria in Plasmodium berghei infected mice. Eur J Immunol. 2013;43(11):2907–2918.10.1002/eji.v43.11
   PubMed Web of Science ®Google Scholar
• Andreani G, Ouellet M, Menasria R, et al. Leishmania infantum amastigotes trigger a subpopulation of human B cells with an immunoregulatory phenotype. PLoS Negl Trop Dis. 2015;9(2):e0003543.10.1371/journal.pntd.0003543
   Google Scholar
• Jeong YI, Hong SH, Choa SH, et al. Induction of IL-10–producing regulatory B cells following Toxoplasma gondii infection is important to the cyst formation. Biochem Biophys Rep. 2016;2016(7):91–97.
   Google Scholar
• Schaut RG, Lamb IM, Toepp AJ, et al. Regulatory IgDhi B cells suppress T cell function via IL-10 and PD-L1 during progressive visceral leishmaniasis. J. Immunol. 2016;196(10):4100–4109.10.4049/jimmunol.1502678
   PubMed Web of Science ®Google Scholar
• Tate EW, Bell AS, Rackham MD, et al. N-Myristoyltransferase as a potential drug target in malaria and leishmaniasis. Parasitology. 2014;141(1):37–49.10.1017/S0031182013000450
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO) [Internet]. World Malaria Report 2015; 2015 [updated 2016 April 20]. Avaliable from: http://www.rbm.who.int.
   Google Scholar
• Schofield L, Grau GE. Immunological processes in malaria pathogenesis. Nat Rev Immunol. 2005;5:722–735.10.1038/nri1686
   PubMed Web of Science ®Google Scholar
• Riley EM, Couper KN, Helmby H, et al. Neuropathogenesis of human and murine malaria. Trends Parasitol. 2010;26(6):277–278.10.1016/j.pt.2010.03.002
   PubMed Web of Science ®Google Scholar
• Clark IA, Budd AC, Alleva LM, et al. Human malarial disease: a consequence of inflammatory cytokine release. Malar J. 2006;5(1):1.
   PubMed Web of Science ®Google Scholar
• Haque A, Best SE, Ammerdorffer A, et al. Type I interferons suppress CD4+ T-cell–dependent parasite control during blood–stage Plasmodium infection. Eur J Immunol. 2011;41(9):2688–2698.10.1002/eji.201141539
   PubMed Web of Science ®Google Scholar
• Asito AS, Moormann AM, Kiprotich C, et al. Alterations on peripheral B cell subsets following an acute uncomplicated clinical malaria infection in children. Malar J. 2008;7(1):1–8.
   Web of Science ®Google Scholar
• Nduati E, Gwela A, Karanja H, et al. The plasma concentration of the B cell activating factor is increased in children with acute malaria. J Infect Dis. 2011;204(6):962–970.10.1093/infdis/jir438
   PubMed Web of Science ®Google Scholar
• Scholzen A, Teirlinck AC, Bijker EM, et al. BAFF and BAFF receptor levels correlate with B cell subset activation and redistribution in controlled human malaria infection. J Immunol. 2014;192(8):3719–3729.10.4049/jimmunol.1302960
   PubMed Web of Science ®Google Scholar
• Scholzen A, Sauerwein RW. How malaria modulates memory: activation and dysregulation of B cells in Plasmodium infection. Trends Parasitol. 2013;29(5):252–262.10.1016/j.pt.2013.03.002
   PubMed Web of Science ®Google Scholar
• Borhis G, Richard Y. Subversion of the B-cell compartment during parasitic, bacterial, and viral infections. BMC Immunol. 2015;16(1):1–10.
   Web of Science ®Google Scholar
• Rest JR. Cerebral malaria in inbred mice. I. A new model and its pathology. Trans R Soc Trop Med Hyg. 1982;76(3):410–415.10.1016/0035-9203(82)90203-6
   PubMed Web of Science ®Google Scholar
• Good MF, Xu H, Wykes M, et al. Development and regulation of cell–mediated immune responses to the blood stages of malaria: implications for vaccine research. Annu Rev Immunol. 2005;23:69–99.10.1146/annurev.immunol.23.021704.115638
   PubMed Web of Science ®Google Scholar
• Amante FH, Haque A, Stanley AC, et al. Immune–mediated mechanisms of parasite tissue sequestration during experimental cerebral malaria. J Immunol. 2010;185(6):3632–3642.10.4049/jimmunol.1000944
   PubMed Web of Science ®Google Scholar
• Fillatreau S, Gray D, Anderton SM. Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol. 2008;8(5):391–397.
   PubMed Web of Science ®Google Scholar
• Margry B, Kersemakers SC, Hoek A, et al. Activated peritoneal cavity B-1a cells possess regulatory B cell properties. PLoS One. 2014;9(2):e88869.10.1371/journal.pone.0088869
   Google Scholar
• Bismuth G, Gary-Gouy H. Signaling functions of the CD5 molecule. Curr Trends Immunol. 1998;1:79–87.
   Google Scholar
• Carsetti R, Rosado MM, Wardmann H. Peripheral development of B cells in mouse and man. Immunol Rev. 2004;197:179–191.10.1111/imr.2004.197.issue-1
   PubMed Web of Science ®Google Scholar
• Lee J, Kuchen S, Fischer R, et al. Identification and characterization of a human CD5+ pre-naive B cell population. J Immunol. 2009;182 (7):4116-4126.10.4049/jimmunol.0803391
   PubMed Web of Science ®Google Scholar
• Griffin DO, Holodick NE, Rothstein TL. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+CD27+CD43+CD70-. J Exp Med. 2011;208(1):67–80.10.1084/jem.20101499
   PubMed Web of Science ®Google Scholar
• Dalloul A. CD5: a safeguard against autoimmunity and a shield for cancer cells. Autoimmun Rev. 2009;8(4):349–353.10.1016/j.autrev.2008.11.007
   PubMed Web of Science ®Google Scholar
• Gary-Gouy H, Sainz-Perez A, Marteau JB, et al. Natural phosphorylation of CD5 in chronic lymphocytic leukemia B cells and analysis of CD5-regulated genes in a B cell line suggest a role for CD5 in malignant phenotype. J Immunol. 2007;179(7):4335–4344.10.4049/jimmunol.179.7.4335
   PubMed Web of Science ®Google Scholar
• Maseda D, Candando KM, Smith SH, et al 2013. Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-γ+ CD4+ T cell numbers during colitis development in mice. J Immunol. 2013;191(5):2780-2795.10.4049/jimmunol.1300649
   PubMed Web of Science ®Google Scholar
• Jeong YI, Hong SH, Cho SH, et al. Induction of IL-10–producing CD1dhighCD5+ regulatory B cells following Babesia microti-infection. PLoS One. 2012;7(10):e46553.10.1371/journal.pone.0046553
   Google Scholar
• Sakkas H, Gartzonika C, Levidiotou S. Laboratory diagnosis of human visceral leishmaniasis. J Vector Borne Dis. 2016;53(1):8–16.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO) [Internet] [updated 2017 March 09]. Available from: http://www.who.int/leishmaniasis/en/.
   Google Scholar
• Chappuis F, Sundar S, Hailu A, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007;5(11):873–882.
   PubMed Web of Science ®Google Scholar
• Stanley AC, Engwerda CR. Balancing immunity and pathology in visceral leishmaniasis. Immunol Cell Biol. 2007;85(2):138–147.10.1038/sj.icb7100011
   PubMed Web of Science ®Google Scholar
• Reithinger R, Dujardin JC, Louzir H, et al. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7(9):581–596.10.1016/S1473-3099(07)70209-8
   PubMed Web of Science ®Google Scholar
• Silveira FT, Lainson R, De Castro Gomes CM, et al. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis. Parasite Immunol. 2009;31(8):423–431.10.1111/pim.2009.31.issue-8
   PubMed Web of Science ®Google Scholar
• Amezcua Vesely MC, Bermejo DA, Montes CL, et al. B-cell response during protozoan parasite infections. J Parasitol Res. 2012;2012:362131.
   PubMedGoogle Scholar
• Kumar R, Nylén S. Immunobiology of visceral leishmaniasis. Front Immunol. 2012;3(251):1–10.
   PubMed Web of Science ®Google Scholar
• Nylén S, Sacks D. Interleukin-10 and the pathogenesis of human visceral leishmaniasis. Trends Immunol. 2007;28(9):378–384.10.1016/j.it.2007.07.004
   PubMed Web of Science ®Google Scholar
• Wanasen N, Xin L, Soong L. Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection. Int J Parasitol. 2008;38(3–4):417–429.10.1016/j.ijpara.2007.08.010
   PubMed Web of Science ®Google Scholar
• Deak E, Jayakumar A, Cho KW, et al. Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation. Eur J Immunol. 2010;40(5):1355–1368.10.1002/eji.200939455
   PubMed Web of Science ®Google Scholar
• Rodrigues V, Cordeiro-da-Silva A, Laforge M, et al. Regulation of immunity during visceral Leishmania infection. Parasit Vectors. 2016;9(118):1–13.
   PubMed Web of Science ®Google Scholar
• Bankoti R, Stäger S. Differential regulation of the immune response in the spleen and liver of mice infected with Leishmania donovani. J Trop Med. 2012;2012:639304.
   PubMedGoogle Scholar
• Schurr E, Kidane K, Yemaneberhan T, et al. Cutaneous leishmaniasis in Ethiopia: I. Lymphocyte transformation and antibody titre. Trop Med Parasitol. 1986;37(4):403–408.
   PubMedGoogle Scholar
• Mengistu G, Akuffo HO, Yemane-Berhan T, et al. Serum antibody specificities to Leishmania aethiopica antigens in patients with localized and diffuse cutaneous leishmaniasis. Parasite Immunol. 1990;12(5):495–495.10.1111/pim.1990.12.issue-4-5
   PubMed Web of Science ®Google Scholar
• Galvao-Castro B, Sá Ferreira JA, Marzochi KF, et al. Polyclonal B cell activation, circulating immune complexes and autoimmunity in human American visceral leishmaniasis. Clin Exp Immunol. 1984;56(1):58–66.
   PubMed Web of Science ®Google Scholar
• Costa CH, Stewart JM, Gomes RB, et al. Asymptomatic human carriers of Leishmania chagasi. Am J Trop Med Hyg. 2002;66(4):334–7l.
   PubMed Web of Science ®Google Scholar
• Gidwani K, Picado A, Ostyn B, et al. Persistence of Leishmania donovani antibodies in past visceral leishmaniasis cases in India. Clin Vaccine Immunol. 2011;18(2):346–348.10.1128/CVI.00473-10
   PubMed Web of Science ®Google Scholar
• Hasker E, Malaviya P, Gidwani K, et al. Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal. PLoS Negl Trop Dis. 2014;8(1):e2657.10.1371/journal.pntd.0002657
   Google Scholar
• Soulas P, Koenig-Marrony S, Julien S, et al. A role for membrane IgD in the tolerance of pathological human rheumatoid factor B cells. Eur J Immunol. 2002;32(9):2623–2634.10.1002/1521-4141(200209)32:9<2623::AID-IMMU2623>3.0.CO;2-0
   PubMed Web of Science ®Google Scholar
• Maity PC, Blount A, Jumaa H, et al. B cell antigen receptors of the IgM and IgD classes are clustered in different protein islands that are altered during B cell activation. Sci Signal. 2015; 8(394):ra93.10.1126/scisignal.2005887
   PubMed Web of Science ®Google Scholar
• Geisberger R, Lamers M, Achatz G. The riddle of the dual expression of IgM and IgD. Immunology. 2006;118(4):429–437.
   PubMed Web of Science ®Google Scholar
• Ranatunga D, Hedrich CM, Wang F, et al. A human IL10 BAC transgene reveals tissue–specific control of IL-10 expression and alters disease outcome. Proc Natl Acad Sci USA. 2009;106(40):17123–17128.10.1073/pnas.0904955106
   PubMed Web of Science ®Google Scholar
• Gonzaga WF, Xavier V, Vivanco BC, et al. B-1 cells contribute to susceptibility in experimental infection with Leishmania (Leishmania) chagasi. Parasitology. 2015;142(12):1506–1515.10.1017/S0031182015000943
   PubMed Web of Science ®Google Scholar
• Murray HW. Interleukin 10 receptor blockade–pentavalent antimony treatment in experimental visceral leishmaniasis. Acta Trop. 2005;93(3):295–295.10.1016/j.actatropica.2004.11.008
   PubMed Web of Science ®Google Scholar
• 134. Faleiro RJ, Kumar R, Hafner LM, et al. Immune regulation during chronic visceral leishmaniasis. PLoS Negl Trop Dis. 2014;8(7):e2914.10.1371/journal.pntd.0002914
   PubMed Web of Science ®Google Scholar
• Gollob KJ, Viana AG, Dutra WO. Immunoregulation in human American leishmaniasis: balancing pathology and protection. Parasite Immunol. 2014;36(8):367–376.10.1111/pim.2014.36.issue-8
   PubMed Web of Science ®Google Scholar
• Singh OP, Sundar S. Immunotherapy and targeted therapies in treatment of visceral leishmaniasis: current status and future prospects. Front Immunol. 2014;5(296):1–9.
   PubMed Web of Science ®Google Scholar
• Khadem F, Uzonna JE. Immunity to visceral leishmaniasis: implications for immunotherapy. Future Microbiol. 2014;9(7):901–915.10.2217/fmb.14.43
   PubMed Web of Science ®Google Scholar